vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and RAPID MICRO BIOSYSTEMS, INC. (RPID). Click either name above to swap in a different company.

CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $11.3M, roughly 1.7× RAPID MICRO BIOSYSTEMS, INC.). CuriosityStream Inc. runs the higher net margin — -19.7% vs -110.8%, a 91.0% gap on every dollar of revenue. On growth, RAPID MICRO BIOSYSTEMS, INC. posted the faster year-over-year revenue change (37.3% vs 35.8%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $-3.3M). Over the past eight quarters, RAPID MICRO BIOSYSTEMS, INC.'s revenue compounded faster (41.8% CAGR vs 26.5%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

Rapid Micro Biosystems, Inc. develops and manufactures automated microbial detection and quality control solutions for the life sciences industry. Its core products serve biopharmaceutical manufacturers, contract development and manufacturing organizations, operating across key global markets including North America, Europe and Asia-Pacific, helping clients cut testing timelines and improve operational efficiency.

CURI vs RPID — Head-to-Head

Bigger by revenue
CURI
CURI
1.7× larger
CURI
$19.2M
$11.3M
RPID
Growing faster (revenue YoY)
RPID
RPID
+1.5% gap
RPID
37.3%
35.8%
CURI
Higher net margin
CURI
CURI
91.0% more per $
CURI
-19.7%
-110.8%
RPID
More free cash flow
CURI
CURI
$7.3M more FCF
CURI
$3.9M
$-3.3M
RPID
Faster 2-yr revenue CAGR
RPID
RPID
Annualised
RPID
41.8%
26.5%
CURI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CURI
CURI
RPID
RPID
Revenue
$19.2M
$11.3M
Net Profit
$-3.8M
$-12.5M
Gross Margin
Operating Margin
-17.6%
-108.2%
Net Margin
-19.7%
-110.8%
Revenue YoY
35.8%
37.3%
Net Profit YoY
-34.6%
-29.3%
EPS (diluted)
$-0.07
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
RPID
RPID
Q4 25
$19.2M
$11.3M
Q3 25
$18.4M
$7.8M
Q2 25
$19.0M
$7.3M
Q1 25
$15.1M
$7.2M
Q4 24
$14.1M
$8.2M
Q3 24
$12.6M
$7.6M
Q2 24
$12.4M
$6.6M
Q1 24
$12.0M
$5.6M
Net Profit
CURI
CURI
RPID
RPID
Q4 25
$-3.8M
$-12.5M
Q3 25
$-3.7M
$-11.5M
Q2 25
$784.0K
$-11.9M
Q1 25
$319.0K
$-11.3M
Q4 24
$-2.8M
$-9.7M
Q3 24
$-3.1M
$-11.3M
Q2 24
$-2.0M
$-12.6M
Q1 24
$-5.0M
$-13.3M
Operating Margin
CURI
CURI
RPID
RPID
Q4 25
-17.6%
-108.2%
Q3 25
-24.5%
-145.1%
Q2 25
2.5%
-167.3%
Q1 25
0.5%
-161.8%
Q4 24
-27.4%
-124.5%
Q3 24
-25.8%
-158.3%
Q2 24
-20.6%
-202.1%
Q1 24
-30.4%
-254.4%
Net Margin
CURI
CURI
RPID
RPID
Q4 25
-19.7%
-110.8%
Q3 25
-20.4%
-146.8%
Q2 25
4.1%
-163.3%
Q1 25
2.1%
-156.3%
Q4 24
-19.9%
-117.6%
Q3 24
-24.3%
-148.9%
Q2 24
-16.4%
-190.1%
Q1 24
-42.0%
-237.4%
EPS (diluted)
CURI
CURI
RPID
RPID
Q4 25
$-0.07
$-0.26
Q3 25
$-0.06
$-0.26
Q2 25
$0.01
$-0.27
Q1 25
$0.01
$-0.26
Q4 24
$-0.05
$-0.22
Q3 24
$-0.06
$-0.26
Q2 24
$-0.04
$-0.29
Q1 24
$-0.09
$-0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
RPID
RPID
Cash + ST InvestmentsLiquidity on hand
$27.3M
$20.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$33.2M
Total Assets
$75.7M
$74.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
RPID
RPID
Q4 25
$27.3M
$20.0M
Q3 25
$27.8M
$18.9M
Q2 25
$28.1M
$18.3M
Q1 25
$33.4M
$18.9M
Q4 24
$32.1M
$16.9M
Q3 24
$33.2M
$22.0M
Q2 24
$39.5M
$37.1M
Q1 24
$38.8M
$22.4M
Stockholders' Equity
CURI
CURI
RPID
RPID
Q4 25
$41.5M
$33.2M
Q3 25
$47.2M
$44.3M
Q2 25
$49.8M
$54.5M
Q1 25
$58.1M
$65.5M
Q4 24
$57.8M
$75.4M
Q3 24
$62.2M
$84.4M
Q2 24
$64.8M
$94.6M
Q1 24
$67.0M
$105.9M
Total Assets
CURI
CURI
RPID
RPID
Q4 25
$75.7M
$74.9M
Q3 25
$74.7M
$84.4M
Q2 25
$78.7M
$75.6M
Q1 25
$85.3M
$85.4M
Q4 24
$86.2M
$98.2M
Q3 24
$87.6M
$105.8M
Q2 24
$90.9M
$117.1M
Q1 24
$94.6M
$127.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
RPID
RPID
Operating Cash FlowLast quarter
$4.0M
$-3.2M
Free Cash FlowOCF − Capex
$3.9M
$-3.3M
FCF MarginFCF / Revenue
20.5%
-29.6%
Capex IntensityCapex / Revenue
0.1%
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-31.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
RPID
RPID
Q4 25
$4.0M
$-3.2M
Q3 25
$4.4M
$-9.1M
Q2 25
$2.8M
$-9.7M
Q1 25
$1.9M
$-9.1M
Q4 24
$3.0M
$-9.9M
Q3 24
$2.3M
$-8.6M
Q2 24
$2.2M
$-10.1M
Q1 24
$666.0K
$-15.5M
Free Cash Flow
CURI
CURI
RPID
RPID
Q4 25
$3.9M
$-3.3M
Q3 25
$-9.1M
Q2 25
$-10.1M
Q1 25
$1.8M
$-9.4M
Q4 24
$-10.0M
Q3 24
$-8.8M
Q2 24
$-10.6M
Q1 24
$-16.1M
FCF Margin
CURI
CURI
RPID
RPID
Q4 25
20.5%
-29.6%
Q3 25
-116.4%
Q2 25
-138.6%
Q1 25
12.2%
-130.2%
Q4 24
-121.8%
Q3 24
-116.0%
Q2 24
-159.8%
Q1 24
-287.1%
Capex Intensity
CURI
CURI
RPID
RPID
Q4 25
0.1%
0.8%
Q3 25
0.0%
0.9%
Q2 25
0.0%
5.0%
Q1 25
0.5%
4.4%
Q4 24
0.0%
1.2%
Q3 24
0.0%
2.9%
Q2 24
0.0%
6.9%
Q1 24
0.0%
10.4%
Cash Conversion
CURI
CURI
RPID
RPID
Q4 25
Q3 25
Q2 25
3.56×
Q1 25
6.03×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CURI
CURI

Segment breakdown not available.

RPID
RPID

Products$9.3M83%
Services$2.0M17%

Related Comparisons